GLS and acute myeloid leukemia: An ever increasing amount of research in adult AML and ALL has been conducted in recent years, which has suggested some interesting inhibitors (e.g., OXPHOS, glutaminase or glycolysis inhibitors) that could synergize with standard chemotherapy and reduce side effects by enhancing specific targeting.